A systematic review and economic evaluation of bisphosphonates for the prevention of fragility fractures

Background: Fragility fractures are fractures that result from mechanical forces that would not ordinarily result in fracture. Objectives: To evaluate the clinical effectiveness and safety of bisphosphonates [alendronic acid (Fosamax® and Fosamax® Once Weekly, Merck Sharp & Dohme Ltd), risedroni...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Sarah Davis, Marrissa Martyn-St James, Jean Sanderson, John Stevens, Edward Goka, Andrew Rawdin, Susi Sadler, Ruth Wong, Fiona Campbell, Matt Stevenson, Mark Strong, Peter Selby, Neil Gittoes
Formato: Artigo
Idioma:Inglês
Publicado em: NIHR Journals Library 2016-10-01
Colecção:Health Technology Assessment
Assuntos:
bisphosphonates
fragility fractures
systematic review
economic analysis
cost-effectiveness
network meta-analysis
Acesso em linha:https://doi.org/10.3310/hta20780
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados